Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Action degraders |
Mechanism ABL2 degraders(ABL proto-oncogene 2, non-receptor tyrosine kinase degraders), EPHB2 degraders(EPH receptor B2 degraders), SIK2 degraders(Serine/threonine-protein kinase SIK2 degraders) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC47H55N9O5S |
InChIKeyKEGVGSFRDCGPAX-INBBZAOVSA-N |
CAS Registry2769850-28-2 |